(Q34963962)

5 August 2017

1 reference

title

Schistosomiasis: from risk assessment to control (English)

1 reference

5 August 2017

0 references

Nils Robert Bergquist

series ordinal

1

1 reference

5 August 2017

publication date

1 July 2002

1 reference

5 August 2017

published in

Trends in Parasitology

1 reference

5 August 2017

volume

18

1 reference

5 August 2017

issue

7

1 reference

5 August 2017

page(s)

309-314

1 reference

Infectious disease. Medical helminthology in the 21st century

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

The global status of schistosomiasis and its control

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Post-transmission schistosomiasis: a new agenda

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Morbidity assessment in urinary schistosomiasis infection through ultrasonography and measurement of eosinophil cationic protein (ECP) in urine

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Assessment of morbidity in Schistosoma haematobium infection: current methods and future tools

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Report of the second satellite symposium on ultrasound in schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

The effectiveness of annual versus biennial mass chemotherapy in reducing morbidity due to schistosomiasis: a prospective study in Gezira-Managil, Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Improvement of ultrasonographic and serologic changes in Schistosoma japonicum-infected patients after treatment with praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Environmental information for prediction of epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Towards an atlas of human helminth infection in sub-Saharan Africa: the use of geographical information systems (GIS).

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Risk maps: transmission and burden of vector-borne diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Urinary schistosomiasis on Pemba Island: low-cost diagnosis for control in a primary health care setting

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Simple school questionnaires can map both Schistosoma mansoni and Schistosoma haematobium in the Democratic Republic of Congo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Diagnosis of schistosomiasis japonica in Chinese schoolchildren by administration of a questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Vector-borne parasitic diseases: new trends in data collection and risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

A global network for the control of snail-borne disease using satellite surveillance and geographic information systems

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

New tools: potential medical applications of data from new and old environmental satellites

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Linkages between FAO agroclimatic data resources and the development of GIS models for control of vector-borne diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Satellite climatology and the environmental risk of Schistosoma mansoni in Ethiopia and east Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Female genital schistosomiasis: facts and hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Clinical findings in female genital schistosomiasis in Madagascar.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Investigation of association between female genital tract diseases and Schistosomiasis japonica infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Praziquantel and the control of schistosomiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

The potential of artemether for the control of schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

The prophylactic effects of artemether against Schistosoma japonicum infections

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

The 1992-1999 World Bank Schistosomiasis Research Initiative in China: outcome and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Antimalarial drug resistance and combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

The development of granulomas in schistosomiasis: genetic backgrounds, regulatory pathways, and specific egg antigen responses that influence the magnitude of disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Vaccine strategies against schistosomiasis: from concepts to clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Schistosoma japonicum infection in the pig as a model for human schistosomiasis japonica

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

Human immune responses to Schistosoma mansoni vaccine candidate antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2902301-2

7 January 2021

10.1016/S1471-4922(02)02301-2

Identifiers

DOI

1 reference

5 August 2017

1 reference